A single-arm, open-label, phase 2 study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi454
Main Authors Socinski, M., Gil, M., Shahidi, J., Chao, G.Y., Villaruz, L.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw383.98